@prefix cas: <http://identifiers.org/cas/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix inchikey: <http://identifiers.org/inchikey/> .
@prefix massbank: <https://identifiers.org/massbank/> .
@prefix mbo: <http://www.massbank.jp/ontology/> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix schema: <https://schema.org/> .
@prefix skos: <http://www.w3.org/2004/02/skos/core#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

massbank:MSBNK-BAFG-CSL2311107123 a mbo:MassSpectrum ;
    dcterms:creator "Kevin S. Jewell; Bj√∂rn Ehlig; Arne Wick" ;
    dcterms:date "2023-11-10"^^xsd:date ;
    dcterms:identifier "MSBNK-BAFG-CSL2311107123" ;
    dcterms:rights "Copyright 2023 Federal Institute of Hydrology, Koblenz, Germany under dl-de/by-2-0" ;
    mbo:analytical_methods_and_conditions [ a mbo:AnalyticalMethods ;
            mbo:ac_instrument "TripleTOF 5600 SCIEX" ;
            mbo:collision_energy "90" ;
            mbo:column_name "Zorbax Eclipse Plus C18 2.1 mm x 150 mm, 3.5 um, Agilent" ;
            mbo:flow_gradient "0 min min 98% A, 1 min 98% A, 2 min 80% A, 16.5 min 2% A, 22 min 2% A, 22.1 min 98% A, 27 min 98% A" ;
            mbo:flow_rate "0.3 mL/min" ;
            mbo:fragmentation_mode "CID" ;
            mbo:instrument_type "LC-ESI-QTOF" ;
            mbo:ion_mode "POSITIVE" ;
            mbo:ms_type "MS2" ;
            mbo:retention_time "10.239 min" ;
            mbo:solvent " ",
                "%",
                ",",
                ".",
                "0",
                "1",
                ":",
                "A",
                "B",
                "F",
                "W",
                "a",
                "c",
                "d",
                "e",
                "i",
                "l",
                "m",
                "n",
                "o",
                "r",
                "t" ] ;
    mbo:compound [ a schema:chemicalsubstance ;
            rdfs:label "1-Oxo-ibuprofen" ;
            mbo:ch_compound_class "Pharmaceutical; Transformation_product" ;
            mbo:ch_exact_mass 2.201099e+02 ;
            rdfs:seeAlso cas:65813-55-0 ;
            schema:inChI "InChI=1S/C13H16O3/c1-8(2)12(14)11-6-4-10(5-7-11)9(3)13(15)16/h4-9H,1-3H3,(H,15,16)" ;
            schema:inChIKey inchikey:RCINGEKPKJQCMO-UHFFFAOYSA-N ;
            schema:molecularFormula "C13H16O3" ;
            schema:name "1-Oxo-ibuprofen" ;
            schema:smiles "CC(C)C(=O)C1=CC=C(C=C1)C(C)C(=O)O" ] ;
    mbo:has_peak [ mbo:intensity 4.2e+00 ;
            mbo:mz 4.30258e+01 ;
            mbo:peak_sequential_number 1 ;
            mbo:relative_intensity 318 ],
        [ mbo:intensity 1.1e+00 ;
            mbo:mz 1.020475e+02 ;
            mbo:peak_sequential_number 10 ;
            mbo:relative_intensity 83 ],
        [ mbo:intensity 2e+00 ;
            mbo:mz 1.030541e+02 ;
            mbo:peak_sequential_number 11 ;
            mbo:relative_intensity 151 ],
        [ mbo:intensity 7e-01 ;
            mbo:mz 1.050686e+02 ;
            mbo:peak_sequential_number 12 ;
            mbo:relative_intensity 53 ],
        [ mbo:intensity 6.9e+00 ;
            mbo:mz 1.150539e+02 ;
            mbo:peak_sequential_number 13 ;
            mbo:relative_intensity 522 ],
        [ mbo:intensity 5e-01 ;
            mbo:mz 1.160605e+02 ;
            mbo:peak_sequential_number 14 ;
            mbo:relative_intensity 38 ],
        [ mbo:intensity 7e-01 ;
            mbo:mz 1.17069e+02 ;
            mbo:peak_sequential_number 15 ;
            mbo:relative_intensity 53 ],
        [ mbo:intensity 1.2e+00 ;
            mbo:mz 1.270565e+02 ;
            mbo:peak_sequential_number 16 ;
            mbo:relative_intensity 91 ],
        [ mbo:intensity 2.4e+00 ;
            mbo:mz 1.280621e+02 ;
            mbo:peak_sequential_number 17 ;
            mbo:relative_intensity 182 ],
        [ mbo:intensity 7e-01 ;
            mbo:mz 1.410715e+02 ;
            mbo:peak_sequential_number 18 ;
            mbo:relative_intensity 53 ],
        [ mbo:intensity 6e-01 ;
            mbo:mz 5.506e+01 ;
            mbo:peak_sequential_number 2 ;
            mbo:relative_intensity 45 ],
        [ mbo:intensity 4e-01 ;
            mbo:mz 5.70754e+01 ;
            mbo:peak_sequential_number 3 ;
            mbo:relative_intensity 30 ],
        [ mbo:intensity 5.1e+00 ;
            mbo:mz 6.50426e+01 ;
            mbo:peak_sequential_number 4 ;
            mbo:relative_intensity 386 ],
        [ mbo:intensity 1.32e+01 ;
            mbo:mz 7.70413e+01 ;
            mbo:peak_sequential_number 5 ;
            mbo:relative_intensity 999 ],
        [ mbo:intensity 1.7e+00 ;
            mbo:mz 7.80486e+01 ;
            mbo:peak_sequential_number 6 ;
            mbo:relative_intensity 129 ],
        [ mbo:intensity 2e+00 ;
            mbo:mz 7.90562e+01 ;
            mbo:peak_sequential_number 7 ;
            mbo:relative_intensity 151 ],
        [ mbo:intensity 1.1e+00 ;
            mbo:mz 8.904e+01 ;
            mbo:peak_sequential_number 8 ;
            mbo:relative_intensity 83 ],
        [ mbo:intensity 7.7e+00 ;
            mbo:mz 9.10558e+01 ;
            mbo:peak_sequential_number 9 ;
            mbo:relative_intensity 583 ] ;
    mbo:mass_spectram_meta_data [ a mbo:MassSpectramMetaData ;
            mbo:precursor_mz 2.211172e+02 ;
            mbo:precursor_type mbo:IT003 ] ;
    mbo:pk_num_peak 18 ;
    mbo:pk_splash "splash10-00ou-9400000000-94b5fcea16fd5d0768a7" ;
    rdfs:comment "Acquisition method: 10.1002/rcm.8541" ;
    skos:definition "1-Oxo-ibuprofen; LC-ESI-QTOF; MS2; 90 V" .

